Prior to joining Kirkland, Fiona was involved in the following representative matters:
- Represented Gilead Sciences in its $4.3 billion acquisition of CymaBay Therapeutics and its $405 million acquisition of MiroBio
- Represented AssetMark in its $2.7 billion sale to GTCR and its strategic alliance with Morningstar and related asset acquisition
- Represented Credo Technology Group in its acquisitions of DustPhotonics and CoMira Solutions
- Represented McKesson Corporation in its sale of minority stake in Medical-Surgical Solutions to Apollo
- Represented Natus Medical in its $1.2 billion acquisition by ArchiMed
- Represented Axar Capital and Phillips Pet Food & Supplies on the joint venture with Central Garden & Pet
- Represented Upgrade in its Series G financing and its $100 million acquisition of Uplift
- Represented Texas Instruments on its $1.2 billion notes offering
- Represented the underwriters in:
- debt offerings of Autodesk, Flex, Intuit, Vishay Intertechnology and Weyerhaeuser
- equity offerings of Mirion Technologies, Intuit, Bloom Energy, IDEAYA Biosciences, RxSight, Recursion Pharmaceuticals and AN2 Therapeutics
